NSEAnalysts/Institutional Investor Meet/Con. Call Updates30 Jul 2026 · 30 Jul 2026, 05:49 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Hikal Limited · HIKAL

✦ AI SummaryResults

Hikal Limited has informed the Exchange about Schedule of meet for Q1 FY27 Post Results Conference Call on Thursday, 6th August 2026 at 05:00 PM (IST). The conference call will be attended by Mr. Sameer Hiremath, Vice Chairman and Managing Director, Mr. Anish Swadi, Senior President, Business Transformation and Animal Health, Mr. Kuldeep Jain, Chief Financial Officer, and Mr. Manoj Mehrotra, President, Pharmaceuticals Business.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Hikal Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

HIKAL_30072026174852_EarningscallintimationJuly302026.pdf

pdf

Download →
View document text
July 30, 2026 BSE Limited, National Stock Exchange of India Limited, P J Towers, Exchange Plaza, Dalal Street, Bandra-Kurla Complex, Bandra, Mumbai - 400 001. Mumbai - 400 051. Scrip Code: 524735 Symbol: HIKAL Dear Sir/Madam, Subject: Intimation of earnings group conference call to discuss the financial and operational performance of the Company for the quarter ended June 30, 2026. Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that, the Company will hold the earnings group conference call to discuss the financial and operational performance for the quarter ended June 30, 2026, on Thursday, August 06, 2026, at 5:00 PM (IST). The details of the group conference call, including the dial-in details are attached herewith. Yours Sincerely, For Hikal Limited Rajasekhar Reddy Company Secretary & Compliance Officer Encl: As above Hikal Ltd. Admin. Office: Great Eastern Chambers, 6th Floor, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India. Tel. + 91–22–6277 0299, + 91–22–6866 0300 Regd. Office: 717/718, Maker Chambers - 5, Nariman Point, Mumbai - 400 021, India. Tel. +91-22 6277 0477. Fax: + 91-22 6277 0500 www.hikal.com info@hikal.com CIN: L24200MH1988PTC048028 Hikal Limited Cordially invites you to Q1 FY27 Post Results Conference Call scheduled on Thursday, 6th August 2026 at 05:00 PM (IST) Participants: Mr. Sameer Hiremath, Vice Chairman and Managing Director Mr. Anish Swadi, Senior President, Business Transformation and Animal Health Mr. Kuldeep Jain, Chief Financial Officer Mr. Manoj Mehrotra, President, Pharmaceuticals Business Diamond Pass registration link: Click Here You are cordially invited Universal Access: +91 22 6280 1309, +91 22 7115 8210 International Numbers (Toll Free): Hong Kong: 800964448 | Singapore : 8001012045 UK : 08081011573 | USA : 18667462133 RSVP Strategic Growth Advisors Pvt. Ltd. Mr. Jigar Kavaiya | jigar.kavaiya@sgapl.net | +91 99206 02034 Ms. Ami Parekh | ami.parekh@sgapl.net | +91 80824 66052